Nectar Lifesciences Limited
NSE:NECLIFE.NS
Overview | Financials
Company Name | Nectar Lifesciences Limited |
Symbol | NECLIFE.NS |
Currency | INR |
Price | 39.69 |
Market Cap | 8,900,919,090 |
Dividend Yield | 0% |
52-week-range | 23.25 - 56.5 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Sanjiv Goyal |
Website | https://www.neclife.com |
An error occurred while fetching data.
About Nectar Lifesciences Limited
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD